These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34504627)

  • 21. Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.
    D'Onofrio G; Panza F; Sancarlo D; Addante F; Solfrizzi V; Cantarini C; Mangiacotti A; Lauriola M; Cascavilla L; Paris F; Lozupone M; Daniele A; Greco A; Seripa D
    J Alzheimers Dis; 2018; 62(2):699-711. PubMed ID: 29480171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.
    Kalaria RN
    Acta Neuropathol; 2016 May; 131(5):659-85. PubMed ID: 27062261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type.
    Todaro L; Puricelli L; Gioseffi H; Guadalupe Pallotta M; Lastiri J; Bal de Kier Joffé E; Varela M; Sacerdote de Lustig E
    Neurobiol Dis; 2004 Mar; 15(2):387-93. PubMed ID: 15006709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of endothelial and neural cell adhesion molecules in prostate cancer.
    Lynch DF; Hassen W; Clements MA; Schellhammer PF; Wright GL
    Prostate; 1997 Aug; 32(3):214-20. PubMed ID: 9254901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort.
    Forti P; Olivelli V; Rietti E; Maltoni B; Pirazzoli G; Gatti R; Gioia MG; Ravaglia G
    Gerontology; 2012; 58(1):41-9. PubMed ID: 21430364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
    Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
    PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased Adiponectin Levels Are a Risk Factor for Cognitive Decline in Spinal Cord Injury.
    Liu FJ; Xu HH; Yin Y; Chen YZ; Xie LY; Li HZ; Wang DD; Shi B
    Dis Markers; 2022; 2022():5389162. PubMed ID: 35082930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Serum Neuropeptide Galanin Level Is a Predictor of Cognitive Dysfunction in Patients with Hip Fracture.
    Xue Z; Zhang K; Luo B; Fan L; Zhao R; Hu G
    Dis Markers; 2021; 2021():9141978. PubMed ID: 34925648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum nitrosative stress levels are increased in Alzheimer disease but not in vascular dementia.
    Dildar K; Sinem F; Gökhan E; Orhan Y; Filiz M
    Alzheimer Dis Assoc Disord; 2010; 24(2):194-7. PubMed ID: 20505437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive screening instruments to identify vascular cognitive impairment: A systematic review.
    Ghafar MZAA; Miptah HN; O'Caoimh R
    Int J Geriatr Psychiatry; 2019 Aug; 34(8):1114-1127. PubMed ID: 31050033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Impairment, P300, and Transforming Growth Factor β1 in Different Forms of Dementia.
    Khedr EM; Gomaa AMS; Ahmed OG; Sayed HMM; Gamea A
    J Alzheimers Dis; 2020; 78(2):837-845. PubMed ID: 33044184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montreal Cognitive Assessment (MoCA): validation study for vascular dementia.
    Freitas S; Simões MR; Alves L; Vicente M; Santana I
    J Int Neuropsychol Soc; 2012 Nov; 18(6):1031-40. PubMed ID: 22676901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief screening for mild cognitive impairment in subcortical ischemic vascular disease: a comparison study of the Montreal Cognitive Assessment with the Mini-Mental State Examination.
    Xu Q; Cao WW; Mi JH; Yu L; Lin Y; Li YS
    Eur Neurol; 2014; 71(3-4):106-14. PubMed ID: 24335198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
    Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
    Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study.
    Sachdev PS; Lipnicki DM; Crawford JD; Brodaty H
    Eur J Neurol; 2019 Sep; 26(9):1161-1167. PubMed ID: 30927497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chinese (cantonese) montreal cognitive assessment in patients with subcortical ischemic vascular dementia.
    You JS; Chen RZ; Zhang FM; Zhou ZY; Cai YF; Li GF
    Dement Geriatr Cogn Dis Extra; 2011 Jan; 1(1):276-82. PubMed ID: 22545038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of neural cell adhesion molecule (NCAM) in autistic serum and postmortem brain.
    Purcell AE; Rocco MM; Lenhart JA; Hyder K; Zimmerman AW; Pevsner J
    J Autism Dev Disord; 2001 Apr; 31(2):183-94. PubMed ID: 11450817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment.
    Tisato V; Rimondi E; Brombo G; Volpato S; Zurlo A; Zauli G; Secchiero P; Zuliani G
    Dement Geriatr Cogn Disord; 2016; 41(5-6):273-80. PubMed ID: 27304551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hidese S; Hattori K; Sasayama D; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Noda T; Yoshida S; Teraishi T; Hori H; Ota M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():12-18. PubMed ID: 28238731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia.
    Yamamoto H; Watanabe T; Miyazaki A; Katagiri T; Idei T; Iguchi T; Mimura M; Kamijima K
    J Am Geriatr Soc; 2005 Apr; 53(4):583-9. PubMed ID: 15817002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.